Ribeiro Ramiro 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Ribeiro Ramiro
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-01+125,000→ 125,000 totalExercise: $28.00Exp: 2034-03-01→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option to purchase will vest and become exercisable as follows: 25% at March 1st, 2025 and the remainder ratably, on a monthly basis, over the remaining three years.